Cargando…
Urinary angiotensin-converting enzyme 2 and metabolomics in COVID-19-mediated kidney injury
BACKGROUND: Angiotensin-converting enzyme 2 (ACE2), the receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is highly expressed in the kidneys. Beyond serving as a crucial endogenous regulator of the renin–angiotensin system, ACE2 also possess a unique function to facilitate a...
Autores principales: | Vergara, Ander, Wang, Kaiming, Colombo, Daniele, Gheblawi, Mahmoud, Rasmuson, Jaslyn, Mandal, Rupasri, Del Nonno, Franca, Chiu, Brian, Scholey, James W, Soler, María José, Wishart, David S, Oudit, Gavin Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494506/ https://www.ncbi.nlm.nih.gov/pubmed/36751625 http://dx.doi.org/10.1093/ckj/sfac215 |
Ejemplares similares
-
Angiotensin Converting Enzyme 2 - at the Heart of the COVID-19 pandemic
por: Oudit, Gavin Y., et al.
Publicado: (2023) -
A Multi-Platform Metabolomics Approach Identifies Urinary Metabolite Signatures That Differentiate Ketotic From Healthy Dairy Cows
por: Zhang, Guanshi, et al.
Publicado: (2021) -
Loss of Angiotensin-Converting Enzyme-2 Leads to the Late Development of Angiotensin II-Dependent Glomerulosclerosis
por: Oudit, Gavin Y., et al.
Publicado: (2006) -
Cancer Metabolomics and the Human Metabolome Database
por: Wishart, David S., et al.
Publicado: (2016) -
Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
por: Patel, Vaibhav B., et al.
Publicado: (2012)